0001181431-14-024975.txt : 20140627 0001181431-14-024975.hdr.sgml : 20140627 20140625160325 ACCESSION NUMBER: 0001181431-14-024975 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140623 FILED AS OF DATE: 20140625 DATE AS OF CHANGE: 20140625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 14940046 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 rrd412255.xml X0306 4 2014-06-23 0 0000879169 INCYTE CORP INCY 0001560782 Daly James M EXPERIMENTAL STATION ROUTE 141 AND HENRY CLAY RD WILMINGTON DE 19880 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2014-06-23 4 M 0 2777 18.32 A 2777 D Common Stock 2014-06-23 4 S 0 2777 56.38 D 0 D Common Stock 2014-06-23 4 M 0 7832 16.62 A 7832 D Common Stock 2014-06-23 4 M 0 502 16.62 A 8334 D Common Stock 2014-06-23 4 S 0 8334 55.92 D 0 D Non-Qualified Stock Option (right to buy) 18.32 2014-06-23 4 M 0 2777 0 D 2020-02-08 Common Stock 2777 50099 D Non-Qualified Stock Option (right to buy) 16.62 2014-06-23 4 M 0 7832 0 D 2019-10-21 Common Stock 7832 124311 D Incentive Stock Option (right to buy) 16.62 2014-06-23 4 M 0 502 0 D 2019-10-21 Common Stock 502 9024 D Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents weighted average sale price. Actual sales prices ranged from $56.12-$56.87. Represents weighted average sale price. Actual sales prices ranged from $55.67-$56.29. /s/ James M. Daly 2014-06-25